Specialist chemotherapy eprescribing, providing a complete end-to-end solution that includes predefined regimens, prescribing, scheduling and dispensing, through to chemotherapy administration and reporting.
iQemo simplifies the prescribing of complex treatments through its intuitive user interface, so our users can spend more time with patients and less time writing prescriptions. Our cloud-based platform can be securely accessed from anywhere, providing up-to-date clinical information on any device with a web browser.
Automatic dose calculations, allergy and sensitivity alerting, decision support linked to pathology & toxicity, drug-to-drug interactions, barcoded wristband and drug scanning and more.
The simple, intuitive user interface and streamlined workflows allow doctors, pharmacists and nurses to spend more of their valuable time caring for and treating patients.
Our secure cloud-platform provides a managed solution without the need to install, host or maintain any software, and can be accessed from almost any internet-connected device.
Audit all levels of your chemotherapy process to streamline the running of your cancer service. iQemo is fully compliant with all national reporting requirements, including SACT.
Our teams have the expertise and knowledge to clearly understand any clinical or technical issues you might run into, so that we can help you quickly and efficiently.
An HL7 integration engine enables us to integrate with any PAS and pathology lab systems, ensuring that critical clinical information is available wherever and whenever you need it.
I find iQemo the best out of the four eprescribing systems I use
The iQemo integration engine can be configured to integrate directly into a hospital PAS system. When a patient is referred to an oncology or haematology consultant, their referral details can be automatically imported directly into iQemo, ready for their treatment plan to be created.
Manually entering patient demographic information is time consuming and increases the risk of duplicate records. The iQemo integration engine solves this.
iQemo is designed and developed to meet the everyday needs of our clinical users, so they can better support the patients in their care.
Predefined and validated regimen templates are not only more efficient, they dramatically improve safety and governance, too.
Oncology-specific drug dosing calculations are built directly into the regimens – saving you time and reducing risk even further.
Intelligent, rule-based decision support, as well as drug-to-drug interactions and allergy checking assist safer prescribing.
iQemo integrates with key hospital systems, so you can securely access the most up to date patient information from any device.
Get email alerts when you need to assess critical infomation. And with cloud access, you can adjust prescriptions from anywhere.
Smart reminders built into iQemo can help you ensure your prescriptions are always processed on time.
“I have been using iQemo for approximately 12 months. The system is extremely easy to use and intuitive. Addition or subtraction of medications and changing of cycles is simple. The support from iQemo has been exceptional, from building new regimens to adapting those to make prescriptions more simple.”
Quick access to all the critical clinical information you need when you're screening a prescription – in one, easy to use interface.
Get a detailed history of all changes made to a prescription (including the reasons why), so you don't need to ask the prescriber.
iQemo automatically reminds prescribers of up and coming prescriptions, so you no longer need to to chase them.
Advanced protocol building capabilities support complex chemotherapy treatments, including multi-arm clinical trials.
Simplified drug ordering with integration into third-party manufacturers' ordering systems, direct from the prescription.
Support for multiple pharmacy units, so only the right parts of a prescription show at the relevant pharmacy.
“Clear, legible and legal prescriptions means fewer interventions are made by pharmacy as we have fewer errors. Ultimately this saves us time. Pharmacy approved templates linked to protocols provide a seamless flow of information that is clinically accurate. Most appropriate antiemetics and TTOs for each regimen ensure patients receive the best level of care and reduced errors.”
Easier chemotherapy administration with all the clinical information, including details of the protocol, in one easy-to-use screen.
Automatic scheduling of treatment plans based on the specified protocol, with support for cascading deferrals through cycles.
With cloud-access and support for mobile devices, record chemotherapy administration without ever leaving the patient's side.
Reduce the risk of error with easy to read administration charts that show drugs in the correct order, based on the treatment plan.
Electronically record toxicity screening, which can then be used to drive rule-based clinical decision support.
Record the patients pre-chemotherapy assessment, administration and adverse events with an intuitive note system.
“iQemo has given me more time in my working day. I no longer have to chase consultants trying to obtain signed prescriptions. I have instant knowledge of when a prescription is prescribed”
iQemo's modular architecture enables us to design a system that seamlessly supports your existing processes and workflows. The iQemo diary automatically schedules chemotherapy treatment plans based on the selected protocol, and supports deferrals that will automatically cascade through all cycles of treatment.
With an electronic drug chart, iQemo enables nurses to record drug administration at the patient's side, ensuring an accurate record is captured in real time. Through smart pump integration, iQemo can even capture a timestamped, 100% accurate record of administration, directly into the chart.
You need your clinical systems to be reliable, safe and responsive. iQemo is built on industry-leading technologies and platforms, to ensure our systems are secure, resilient, high-performing and scalable.
Load-balanced and redundant hosting ensures almost constant availability, across systems that are regularly penetration tested to ensure a secure and robust environment.
Biosimilar switching is becoming more common as Rituximab, Trastuzumab and Bevacizumab all have biosimilars on the market. Due to stock shortages and contract prices, there may be a need to switch biosimilars more regularly. This will become more common as additional biosimilar products come to the market. iQemo can facilitate biosimilar switching through several mechanisms.Read more
Beyond the standard benefits of e-prescribing, iQemo provides many additional features that will help your organisation further improve the safety of its patients receiving chemotherapy.Read more
An explanation of the iQemo settings hierarchy, from drug-formulary to drug-level, and how that relates to dose capping.Read more
Sign up to our newsletter and stay updated with industry-leading advice, insight and more…